Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F6XSK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $60,273
Award facts
- Contract value 100% obligated
- $60,272.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $60,272.76 on September 8, 2025, for the supply of Soliris 300 mg/30 ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was issued without a set-aside designation under the Medical Supply Chain program, a defense-focused federal agency that supports pharmaceutical procurement for military healthcare systems. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply chain, drawing from its substantial $499,999,999 indefinite delivery contract with the Defense Logistics Agency under the SPE2DB program, which remains valid through November 2026.
DMS Pharmaceutical Group's extensive experience distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide positioned the company to secure this delivery order. The company's track record of supplying specialized pharmaceutical products—ranging from oncology treatments to injectable medications—demonstrates its capability to meet federal healthcare procurement requirements. This award reflects the company's ongoing role in supporting military medical supply needs through efficient distribution of critical pharmaceutical products to defense healthcare sites.
Quick answers
Who was awarded contract SPE2DX25F6XSK?
SPE2DX25F6XSK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 8, 2025.
How much is contract SPE2DX25F6XSK worth?
The government has obligated $60,273 on SPE2DX25F6XSK.
Is contract SPE2DX25F6XSK an order under another contract?
Yes. SPE2DX25F6XSK is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XSK competed?
The extent of competition for SPE2DX25F6XSK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award